Back to Journals » Drug Design, Development and Therapy » Volume 6

Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, Fingolimod will change therapeutic paradigm approach

Total article views   Abstract views HTML views PDF downloads Totals
14,473 Dovepress* 10,358 534+ 2,554 10,892
PubMed Central* 44 3,537 1,544 3,581
Totals 10,402 4,071 4,098 14,473
*Since 19 July 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
11 0 0 0 3 8

View citations on PubMed Central and Google Scholar